X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-13 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.55 | -40,000 | 762,656 | -5% | -$301,800 | |||||
| DM | 2024-10-02 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $6.12 | -40,000 | 762,656 | -5% | -$244,800 | |||||
| DM | 2024-09-04 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $6.09 | -40,000 | 762,656 | -5% | -$243,600 | |||||
| DM | 2024-08-07 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $6.86 | -50,000 | 758,738 | -6% | -$343,000 | |||||
| DM | 2024-07-10 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.48 | -100,000 | 758,738 | -12% | -$747,500 | |||||
| DM | 2024-06-05 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $8.71 | -100,000 | 708,738 | -12% | -$871,000 | |||||
| DM | 2024-05-01 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $8.10 | -100,000 | 834,820 | -11% | -$810,000 | |||||
| DM | 2024-04-03 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $8.93 | -130,000 | 938,524 | -12% | -$1,160,900 | |||||
| D | 2024-03-28 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $10.10 | -65,000 | 1,043,524 | -6% | -$656,500 | |||||
| D | 2024-03-06 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $11.73 | -61,319 | 1,108,524 | -5% | -$719,505 | |||||
| D | 2024-02-07 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $9.22 | -48,272 | 774,703 | -6% | -$444,981 | |||||
| D | 2024-01-03 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $9.50 | -55,853 | 791,725 | -7% | -$530,567 | |||||
| D | 2023-12-06 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.49 | -59,829 | 791,328 | -7% | -$448,394 | |||||
| D | 2023-11-01 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $5.17 | -62,177 | 836,820 | -7% | -$321,301 | |||||
| D | 2023-10-04 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.21 | -59,794 | 842,747 | -7% | -$431,025 | |||||
| D | 2023-09-06 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $8.81 | -58,765 | 871,291 | -6% | -$517,442 | |||||
| D | 2023-08-02 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $13.04 | -65,015 | 890,719 | -7% | -$847,712 | |||||
| D | 2023-07-12 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $12.54 | -56,818 | 915,810 | -6% | -$712,242 | |||||
| D | 2023-06-07 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $9.05 | -56,436 | 916,378 | -6% | -$510,808 | |||||
| D | 2023-05-03 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $4.79 | -58,073 | 953,225 | -6% | -$278,335 | |||||
| AD | 2022-01-05 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.39 | -18,500 | 582,805 | -3% | -$136,669 | |||||
| DM | 2023-04-05 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $6.60 | -53,327 | 906,710 | -6% | -$351,710 | |||||
| DM | 2023-03-08 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $8.05 | -110,890 | 938,787 | -11% | -$892,894 | |||||
| D | 2023-03-02 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.92 | -21,000 | 940,927 | -2% | -$166,268 | |||||
| D | 2023-02-02 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $9.22 | -21,000 | 942,273 | -2% | -$193,561 | |||||
| D | 2023-01-05 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.39 | -21,000 | 525,805 | -4% | -$155,131 | |||||
| D | 2022-12-01 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $9.04 | -39,710 | 582,805 | -6% | -$358,947 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |